Journal of Gynecologic Oncology

Korean Society of Gynecologic Oncology (대한부인종양학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiological characteristics of ovarian cancer in Korea

  • Park, Bo-Young (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Park, So-Hee (Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Kim, Tae-Joong (Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Ma, Seung-Hyun (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Kim, Byoung-Gie (Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Yong-Man (Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jae-Weon (Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kang, Sok-Bom (Department of Gynecologic Oncology, National Cancer Center) ;
  • Kim, Jae-Hoon (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Tae-Jin (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Yoo, Keun-Young (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Park, Sue-K. (Department of Preventive Medicine, Seoul National University College of Medicine)
  • Received : 2010.10.20
  • Accepted : 2010.11.27
  • Published : 2010.12.20
⟨ Previous Next ⟩

Abstract

Objective: This study was conducted to examine recent trends in ovarian cancer incidence and mortality and secular trends in demographic factors in Korea. Methods: With the data from Korea Central Cancer Registry, International Agency for Research on Cancer, Korean Death Registry, and World Health Organization's Statistical Information System, we calculated age-standardized incidence and mortality rates for ovarian cancer. Also we estimated future incidence of ovarian and cervical cancer using linear regression model. To assess the demographic trend, data from national surveys in Korea or results from published papers were searched. Results: Ovarian cancer incidence rate was similar to that in women worldwide but lower than those in Western countries, and the trend has been increased steadily. Ovarian cancer-related mortality rates have been increasing in Korea, even though those in western and some Asian countries, such as China, have been decreasing. Age-specific incidence rate and mortality rate showed steep increases with advancing age. The incidence rate of ovarian cancer was estimated to surpass that of uterine cervix cancer in 2015. Korea showed rapid changes in nutritional, reproductive, and anthropometric factors. Conclusion: These recent trends in ovarian cancer incidence and mortality may be partly attributed to gradual westernizing of life styles and to changes in socio-demographic behavior factors. In particular, the increasing trend in ovarian cancer mortality in Korea may be attributed to a real rise in mortality as well as, in part, a decline in misclassification bias related to an increase in the proportion of deaths confirmed by physician diagnosis.

Keywords

References

  1. Brewster WR. Temporal trends in ovarian cancer: incidence and mortality across Europe. Nat Clin Pract Oncol 2005; 2: 286-7. https://doi.org/10.1038/ncponc0198
  2. Olaitan A, Mocroft A, Jacobs I. Patterns in the incidence of age-related ovarian cancer in South East England 1967-1996. BJOG 2000; 107: 1094-6. https://doi.org/10.1111/j.1471-0528.2000.tb11106.x
  3. World Health Organization. Globocan 2008 [Internet]. Lyon: International Agency for Research on Cancer; [cited 2010 Jul 15]. Available from: http://globocan.iarc.fr/.
  4. Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2007), cancer prevalence (2007) and survival (1993-2007) in Korea. Seoul: Ministry for Health, Welfare and Family Affairs; 2009.
  5. Kim K, Zang R, Choi SC, Ryu SY, Kim JW. Current status of gynecological cancer in China. J Gynecol Oncol 2009; 20: 72-6. https://doi.org/10.3802/jgo.2009.20.2.72
  6. Ahn YO. Cancer registration in Korea: the present and furtherance. J Prev Med Public Health 2007; 40: 265-72. https://doi.org/10.3961/jpmph.2007.40.4.265
  7. Segi M, Kurihara M. Cancer mortality for selected sites in 24 countries. Sandai: Department of Public Health, Tohoku University of Medicine; 1966.
  8. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, Vol. VIII. IARC scientific publication No. 155. Lyon: International Agency for Research on Cancer; 2002.
  9. Korea National Statistical Office. Korean Statistical Information System (KOSIS): Annual report on the cause of death statistics. 1983-2005 [Internet]. Daejeon: Korea National Statistical Office; [cited 2010 Jul 15]. Available from: http://www.kosis.kr.
  10. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007 [Internet]. Bethesda: National Cancer Institute; 2009 [cited 2010 Jul 15]. Available from: http://seer.cancer.gov/csr/1975_2007/.
  11. World Health Organization, Global Healrh Observatory (GHO). Mortality and Burden of Diseases Estimates for WHO Member States in 2004, Table 1: Estimated total female deaths, by cause and WHO member state, 2004 [Internet]. Geneva: World Health Organization; 2009 [cited 2010 Jul 15]. Available from: http://apps.who.int/ghodata/resources/gbddeathdalycountryestimates_female_2004.xls.
  12. Ministry of Health & Welfare, Korean Centers for Disease Control and Prevention. Korea National Health & Nutrition Examination Survey [Internet]. Seoul: Ministry of Health and Welfare; [cited 2010 Sep 14]. Available from: http://knhanes.cdc.go.kr/.
  13. Cho GJ, Park HT, Shin JH, Hur JY, Kim YT, Kim SH, et al. Age at menarche in a Korean population: secular trends and influencing factors. Eur J Pediatr 2010; 169: 89-94. https://doi.org/10.1007/s00431-009-0993-1
  14. Park MJ, Lee IS, Shin EK, Joung H, Cho SI. The timing of sexual maturation and secular trends of menarchial age in Korean adolescents. Korean J Pediatr 2006; 49: 610-6. https://doi.org/10.3345/kjp.2006.49.6.610
  15. Park SK, Kang D, Kim Y, Yoo KY. Epidemiologic characteristics of the breast cancer in Korea. J Korean Med Assoc 2009; 52: 937-45. https://doi.org/10.5124/jkma.2009.52.10.937
  16. Korea Institute for Health and Social Affairs (KIHASA). National survey data of marriage and fertility transition in 2009 [Internet]. Seoul: Ministry of Health and Welfare; 2009 [cited 2010 Jul 15]. Available from: http://www.mw.go.kr.
  17. Korean Statistical Information Service. The population statistics [Internet]. Daejeon: Korea National Statistical Office; [cited 2010 Sep 13]. Available from: http://www.kosis.kr/.
  18. Korea National Statistical Office. Population projections for Korea: 2005-2050 [Internet]. Daejeon: Korea National Statistical Office; [cited 2010 Jul 15]. Available from: http://kostat.go.kr.
  19. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1184-203. https://doi.org/10.1093/oxfordjournals.aje.a116427
  20. Kolahdooz F, van der Pols JC, Bain CJ, Marks GC, Hughes MC, Whiteman DC, et al. Meat, fish, and ovarian cancer risk: results from 2 Australian case-control studies, a systematic review, and meta-analysis. Am J Clin Nutr 2010; 91: 1752-63. https://doi.org/10.3945/ajcn.2009.28415
  21. Ushijima K. Current status of gynecologic cancer in Japan. J Gynecol Oncol 2009; 20: 67-71. https://doi.org/10.3802/jgo.2009.20.2.67
  22. National Cancer Information Center [Internet]. Goyang: National Cancer Center; [cited 2010 Jul 15]. Available from: http://www.cancer.go.kr/cms/statics/incidence/index.html#4.
  23. Kim NI, Lee JH. An analytical review of the methods computing age at first marriage. Korean J Popul Stud 1995; 18: 1-22.
  24. Korea National Statistical Office. The pilot result of birth statistics in 2009 [Internet]. Daejeon: Korea National Statistical Office; [cited 2010 Jul 15]. Available from: http://kostat.go.kr/.
  25. Size Korea. Comparison of estimates according to year [Internet]. Gwacheon: Korea Ministry of Commerce, Industry and Energy; [cited 2010 Oct 10]. Available from: http://sizekorea.kats.go.kr/.
  26. Hirabayashi Y, Marugame T. Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO Mortality Database. Jpn J Clin Oncol 2009; 39: 860-1. https://doi.org/10.1093/jjco/hyp168
  27. Nugent D, Salha O, Balen AH, Rutherford AJ. Ovarian neoplasia and subfertility treatments. Br J Obstet Gynaecol 1998; 105: 584-91. https://doi.org/10.1111/j.1471-0528.1998.tb10171.x
  28. Brinton LA, Moghissi KS, Scoccia B, Westhoff CL, Lamb EJ. Ovulation induction and cancer risk. Fertil Steril 2005; 83: 261-74. https://doi.org/10.1016/j.fertnstert.2004.09.016
  29. Parazzini F, Franceschi S, La Vecchia C, Fasoli M. The epidemiology of ovarian cancer. Gynecol Oncol 1991; 43: 9-23. https://doi.org/10.1016/0090-8258(91)90003-N
  30. Hwang N. The status of infertility and policy direction in Korea. Health Welf Policy Forum 2003; 82: 88-97.
  31. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998; 90: 1774-86. https://doi.org/10.1093/jnci/90.23.1774
  32. Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control 2002; 13: 807-11. https://doi.org/10.1023/A:1020678100977
  33. Zografos GC, Panou M, Panou N. Common risk factors of breast and ovarian cancer: recent view. Int J Gynecol Cancer 2004; 14: 721-40. https://doi.org/10.1111/j.1048-891X.2004.14503.x
  34. Kim HR, Hwang NM, Sim JE, Kim EJ. Analysis of the factors related to nutrition and policy issues for healthy future generation [Internet]. Seoul: Korea Institute for Health and Social Affairs (KIHASA); 2008 [cited 2010 Sep 13]. Available from: http://211.252.146.15/pub/docu/kr/AK/AA/AKAA2008AAQ/AKAA-2008-AAQ.PDF.
  35. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008; 371: 303-14. https://doi.org/10.1016/S0140-6736(08)60167-1
  36. Jo MW, Khang YH, Yun S, Lee JY, Lee MS, Lee SI. Proportion of death certificates issued by physicians and associated factors in Korea, 1990-2002. J Prev Med Public Health 2004; 37: 345-52.

Cited by

  1. Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer vol.23, pp.3, 2010, https://doi.org/10.1097/cad.0b013e32834ea5d0
  2. Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer vol.19, pp.5, 2010, https://doi.org/10.1245/s10434-011-1943-5
  3. Korean Epithelial Ovarian Cancer Study (Ko-EVE): Protocols and Interim Report vol.13, pp.8, 2010, https://doi.org/10.7314/apjcp.2012.13.8.3731
  4. Diagnosis of a Malignant Tumor in a Patient with an Adnexal Mass Using Endoscopic Ultrasound Elastography vol.18, pp.2, 2010, https://doi.org/10.15746/sms.12.026
  5. Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model vol.5, pp.None, 2010, https://doi.org/10.2147/ceor.s42170
  6. Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study vol.56, pp.4, 2010, https://doi.org/10.5468/ogs.2013.56.4.234
  7. Ovarian cancer mortality among women aged 40-79 years in relation to reproductive factors and body mass index: latest evidence from the Japan Collaborative Cohort study vol.24, pp.3, 2010, https://doi.org/10.3802/jgo.2013.24.3.249
  8. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells vol.44, pp.3, 2010, https://doi.org/10.3892/ijo.2013.2232
  9. High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer vol.25, pp.4, 2010, https://doi.org/10.3802/jgo.2014.25.4.334
  10. CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation vol.35, pp.4, 2010, https://doi.org/10.3892/ijmm.2015.2089
  11. Reduced expression of HSP27 following HAD-B treatment is associated with Her2 downregulation in NIH:OVCAR-3 human ovarian cancer cells vol.12, pp.3, 2015, https://doi.org/10.3892/mmr.2015.3876
  12. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012 vol.27, pp.1, 2010, https://doi.org/10.3802/jgo.2016.27.e5
  13. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer vol.140, pp.3, 2010, https://doi.org/10.1016/j.ygyno.2015.12.006
  14. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer vol.27, pp.2, 2010, https://doi.org/10.3802/jgo.2016.27.e20
  15. Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea vol.16, pp.None, 2010, https://doi.org/10.1186/s12885-015-2040-0
  16. Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer vol.56, pp.2, 2010, https://doi.org/10.1002/mc.22498
  17. Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/5307459
  18. Comparison of gynecologic cancer risk factors, incidence and mortality trends between South Korea and Israel, 1999-2013 vol.48, pp.10, 2010, https://doi.org/10.1093/jjco/hyy111
  19. Comparison of gynecologic cancer risk factors, incidence and mortality trends between South Korea and Israel, 1999-2013 vol.48, pp.10, 2010, https://doi.org/10.1093/jjco/hyy111
  20. Is Second Look Laparoscopy for Diagnosing Remaining Ovarian Cancer Appropriate Further Treatment? vol.42, pp.2, 2010, https://doi.org/10.12771/emj.2019.42.2.15
  21. Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis vol.19, pp.1, 2010, https://doi.org/10.1186/s12885-019-6139-6
  22. Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968-2012 vol.20, pp.12, 2010, https://doi.org/10.31557/apjcp.2019.20.12.3563